Circulating RNA as a Tumor Marker

Abstract: Cancer is commonly associated with the inappropriate mRNA expression of nonmutated genes. Recently, several tumor‐associated RNA species, including tyrosinase mRNA and telomerase RNA, have been demonstrated in plasma and serum. The presence of tumor RNA in plasma and serum affords the opportunity to diagnose or stratify patients with cancer when tissue is not readily available. To exemplify the potential for pharmacogenomic and phenotypic stratification of the cancer patient, we evaluated serum for 5T4 mRNA. 5T4 is a trophoblast glycoprotein frequently overexpressed in epithelial malignancies that provides a potential target for cancer therapeutics. Serum was collected from 19 patients with advanced breast cancer (5 patients) or non‐small‐cell lung cancer (14 patients), and from 25 normal control volunteers having amplifiable RNA. RNA extracted from the serum was RT‐PCR amplified using heminested, two‐stage reactions, with products detected by gel electrophoresis. 5T4 mRNA was reproducibly detected in 8/19 (42%) cancer patient sera, including 2/5 breast cancer patient sera and 6/14 lung cancer patient sera, but in only 3/25 (12%) normal control sera (p= 0.035). The potential for circulating mRNA to identify patients who might benefit from a 5T4‐directed therapy offers an example of the utility of circulating RNA as a tumor marker.

[1]  P. Stern,et al.  A 72 kD trophoblast glycoprotein defined by a monoclonal antibody. , 1988, British Journal of Cancer.

[2]  P. Stern,et al.  Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma. , 1994, British Journal of Cancer.

[3]  P. Stern,et al.  Isolation and characterization of 5T4, a tumour‐associated antigen , 1990, International journal of cancer.

[4]  David Sidransky,et al.  Microsatellite alterations in serum DNA of head and neck cancer patients , 1996, Nature Medicine.

[5]  P. Stern,et al.  Isolation of a cDNA encoding 5T4 oncofetal trophoblast glycoprotein. An antigen associated with metastasis contains leucine-rich repeats. , 1994, The Journal of biological chemistry.

[6]  F. A. Benko,et al.  Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA. , 2000, Journal of the National Cancer Institute.

[7]  P. Stern,et al.  Investigation of expression of 5T4 antigen in cervical cancer. , 1990, British Journal of Cancer.

[8]  C. Meijer,et al.  Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  S. Groshen,et al.  Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. , 2000, Journal of the National Cancer Institute.

[10]  P. Stern,et al.  Immunohistological distribution of 5T4 antigen in normal and malignant tissues. , 1990, British Journal of Cancer.

[11]  K. W. King,et al.  Organisation of the mouse and human 5T4 oncofoetal leucine-rich glycoprotein genes and expression in foetal and adult murine tissues. , 1999, Biochimica et biophysica acta.

[12]  V. Vasioukhin,et al.  K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. , 1997, Gastroenterology.

[13]  L. Kwak,et al.  Detection of tumor messenger RNA in the serum of patients with malignant melanoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  P. Stern,et al.  The expression of 5T4 antigen in colorectal and gastric carcinoma. , 1992, British Journal of Cancer.

[15]  H. Bonnefoi,et al.  Telomerase RNA as a detection marker in the serum of breast cancer patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  S. Ugurel,et al.  Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma. , 2001, Oncology reports.

[17]  S. Leung,et al.  Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. , 1999, Clinical chemistry.

[18]  V A Memoli,et al.  Soluble normal and mutated DNA sequences from single-copy genes in human blood. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.